UK | pharmaphorum

UK

News

Teva’s smart inhaler launches in first European market

Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disord

News

ABPI slams UK government consultation on drug levy

For all the UK government’s rhetoric on supporting the life sciences industry, it seems destined to alienate the very sector it is trying to court.

News

London’s life sciences skyscraper gets planning consent

Plans for a major life sciences development at Canary Wharf in London, UK, have been approved by the local authorities, allowing the project to go ahead.

News

UK must not overlook manufacturing in life sciences drive

To meet its aspiration of becoming a life sciences superpower, the UK must not only discover and develop new medicines – it must also be able to manufacture them at scale,

News

Last year’s UK biotech financing dip extends into 2023

The first quarter of 2023 saw just £295 million raised by UK-based life sciences and biotech companies, signalling that investor confidence remains low after a disappointi

News

UK generics body makes bid to join voluntary scheme talks

The UK’s voluntary system of revenue rebates to limit rises in medicines spending is already causing deep upset among branded drug manufacturers as clawbacks rise.

Teva’s smart inhaler launches in first European market

ABPI slams UK government consultation on drug levy

London’s life sciences skyscraper gets planning consent

UK must not overlook manufacturing in life sciences drive

Last year’s UK biotech financing dip extends into 2023

UK generics body makes bid to join voluntary scheme talks

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

UK

Editor's Picks